Back to mobile site

Integra LifeSciences (IART) PT Lowered to $22 at Citizens on Specialty Surgical Business Headwinds

October 22, 2026 5:13 AM EDT Send to a Friend
Citizens analyst David Turkaly lowered the price target on Integra LifeSciences (NASDAQ: IART) to $22.00 (from $25.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login